nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—POLE4—brain—conduct disorder	0.13	0.211	CbGeAlD
Cladribine—PNP—brain—conduct disorder	0.0721	0.117	CbGeAlD
Cladribine—RRM2B—brain—conduct disorder	0.067	0.108	CbGeAlD
Cladribine—POLE3—brain—conduct disorder	0.0633	0.102	CbGeAlD
Cladribine—NR5A1—brain—conduct disorder	0.0613	0.0991	CbGeAlD
Cladribine—POLE—brain—conduct disorder	0.0483	0.078	CbGeAlD
Cladribine—POLA1—brain—conduct disorder	0.0416	0.0673	CbGeAlD
Cladribine—RRM2—brain—conduct disorder	0.0398	0.0643	CbGeAlD
Cladribine—RRM1—brain—conduct disorder	0.033	0.0534	CbGeAlD
Cladribine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.03	0.0788	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—WASF1—conduct disorder	0.0298	0.0782	CbGpPWpGaD
Cladribine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0298	0.0782	CbGpPWpGaD
Cladribine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.028	0.0734	CbGpPWpGaD
Cladribine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0278	0.0729	CbGpPWpGaD
Cladribine—DCK—brain—conduct disorder	0.0257	0.0415	CbGeAlD
Cladribine—RRM2—E2F transcription factor network—WASF1—conduct disorder	0.0246	0.0644	CbGpPWpGaD
Cladribine—SLC22A1—brain—conduct disorder	0.0219	0.0354	CbGeAlD
Cladribine—POLA1—E2F transcription factor network—WASF1—conduct disorder	0.0168	0.0441	CbGpPWpGaD
Cladribine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0156	0.0409	CbGpPWpGaD
Cladribine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0145	0.0381	CbGpPWpGaD
Cladribine—ABCG2—brain—conduct disorder	0.0143	0.0231	CbGeAlD
Cladribine—RRM2B—Direct p53 effectors—EP300—conduct disorder	0.00859	0.0225	CbGpPWpGaD
Cladribine—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00791	0.0208	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00788	0.0207	CbGpPWpGaD
Cladribine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00738	0.0193	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—EP300—conduct disorder	0.00721	0.0189	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CGA—conduct disorder	0.00644	0.0169	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—EP300—conduct disorder	0.00593	0.0156	CbGpPWpGaD
Cladribine—PNP—Metabolism—CGA—conduct disorder	0.00558	0.0146	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—POLR3A—conduct disorder	0.00508	0.0133	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00475	0.0125	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00443	0.0116	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00409	0.0107	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—EP300—conduct disorder	0.00406	0.0106	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00364	0.00955	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00339	0.0089	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00334	0.00875	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CGA—conduct disorder	0.00321	0.00841	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—COMT—conduct disorder	0.00291	0.00762	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—MAOA—conduct disorder	0.00289	0.00757	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CGA—conduct disorder	0.00264	0.00693	CbGpPWpGaD
Cladribine—PNP—Metabolism—COMT—conduct disorder	0.00252	0.00661	CbGpPWpGaD
Cladribine—PNP—Metabolism—MAOA—conduct disorder	0.0025	0.00656	CbGpPWpGaD
Cladribine—DCK—Metabolism—CGA—conduct disorder	0.00247	0.00647	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00241	0.00631	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00229	0.006	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00227	0.00595	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00213	0.00559	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00212	0.00555	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—EP300—conduct disorder	0.00202	0.0053	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—EP300—conduct disorder	0.00198	0.0052	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00198	0.00519	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00196	0.00513	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00188	0.00493	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00182	0.00478	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—EP300—conduct disorder	0.00177	0.00465	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—COMT—conduct disorder	0.00175	0.00459	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00174	0.00456	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—COMT—conduct disorder	0.00163	0.00428	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00162	0.00425	CbGpPWpGaD
Cladribine—RRM1—Metabolism—COMT—conduct disorder	0.00145	0.0038	CbGpPWpGaD
Cladribine—RRM1—Metabolism—MAOA—conduct disorder	0.00144	0.00377	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—EP300—conduct disorder	0.00133	0.00349	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—EP300—conduct disorder	0.00128	0.00335	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—EP300—conduct disorder	0.00125	0.00327	CbGpPWpGaD
Cladribine—RRM2—Metabolism—COMT—conduct disorder	0.00119	0.00313	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—EP300—conduct disorder	0.00119	0.00312	CbGpPWpGaD
Cladribine—RRM2—Metabolism—MAOA—conduct disorder	0.00118	0.0031	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—EP300—conduct disorder	0.00114	0.003	CbGpPWpGaD
Cladribine—DCK—Metabolism—COMT—conduct disorder	0.00111	0.00292	CbGpPWpGaD
Cladribine—DCK—Metabolism—MAOA—conduct disorder	0.00111	0.0029	CbGpPWpGaD
Cladribine—PNP—Metabolism—EP300—conduct disorder	0.00108	0.00283	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CGA—conduct disorder	0.000988	0.00259	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CGA—conduct disorder	0.000977	0.00256	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CGA—conduct disorder	0.000911	0.00239	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—EP300—conduct disorder	0.00091	0.00239	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—EP300—conduct disorder	0.000814	0.00213	CbGpPWpGaD
Cladribine—RRM1—Metabolism—EP300—conduct disorder	0.000621	0.00163	CbGpPWpGaD
Cladribine—RRM2—Metabolism—EP300—conduct disorder	0.000511	0.00134	CbGpPWpGaD
Cladribine—DCK—Metabolism—EP300—conduct disorder	0.000478	0.00125	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—COMT—conduct disorder	0.000446	0.00117	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MAOA—conduct disorder	0.000443	0.00116	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—COMT—conduct disorder	0.000441	0.00116	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000438	0.00115	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—COMT—conduct disorder	0.000411	0.00108	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000408	0.00107	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—EP300—conduct disorder	0.000191	0.000501	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—EP300—conduct disorder	0.000189	0.000496	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—EP300—conduct disorder	0.000176	0.000462	CbGpPWpGaD
